Peptide Mixing
Compatibility Guide

The most commonly combined pair. Both are stable in BAC water at similar pH (~6–7). Can share a syringe. Community consensus: combine, inject once. No documented interaction or precipitation.

Widely used together in the Wolverine Stack. Compatible in BAC water. PEG-MGF is stable at physiological pH. Combine in syringe without concern.

Sold as a pre-blended combination by most compounding pharmacies — the most widely used peptide combination commercially. Completely stable mixed. Standard practice to combine.

Some community reports of mild cloudiness when combined. Not universally reported. If cloudiness appears on mixing — use separate syringes. If solution remains clear — generally considered acceptable.

Both GHRH/GHRP class. Similar pH range and stability profile. Commonly combined in anti-ageing clinic protocols. Pre-blended versions commercially available.

Pharmacologically redundant. Tesamorelin is a GHRH analog — it stimulates the pituitary to release endogenous growth hormone. HGH (somatropin) is exogenous growth hormone. Stacking a GH-releasing stimulator on top of GH itself adds no benefit — exogenous HGH already provides supraphysiological levels, and tesamorelin's downstream effect (pituitary GH release) is overridden via negative feedback. The combination delivers no additive outcome and doubles cost, injection burden, and side-effect risk (water retention, IGF-1 elevation, insulin resistance). Pick one approach: tesamorelin (or another GHRH/GHRP) for natural pulsatile release, OR HGH for direct supplementation. Not both.

All three are GH secretagogues acting on the same pathway. Tesamorelin is a long-acting GHRH analog; CJC-1295 is also a GHRH analog; Ipamorelin is a GHRP. Combining tesamorelin with CJC-1295 is redundant (two GHRH analogs). Combining tesamorelin with ipamorelin alone is sometimes used to add the GHRP synergy without doubling up GHRH — but tesamorelin's long half-life makes precise pulsatile dosing difficult. If running this stack, separate syringes and timing matter. No chemical mixing incompatibility.

HGH is a fragile 191-amino-acid protein supplied in pharmaceutical preparations with specific buffer and pH formulations. Mixing in syringe with other peptides introduces pH disruption, potential denaturation, and contamination risk. Always inject alone. Timing of other peptides can be same-day but separate syringe and ideally separate site.

GLP-1 agonists should always be injected alone. Pharmaceutical preparations are formulated at specific pH and buffer conditions. Mixing introduces contamination risk and pH disruption. Always separate syringe.

Same principle as semaglutide. GLP-1/GIP dual agonist — inject alone. No mixing with other peptides.

Both melanocortin agonists — additive cardiovascular effects (blood pressure elevation, nausea). Never combine doses. If using both, separate timing by at least 48 hours and start with minimum doses of each individually to assess tolerance.

No documented chemical incompatibility. However — these are typically run on different schedules (Epitalon 10-day courses, Thymosin α-1 twice weekly). Separate injection schedules mean mixing rarely arises. If same-day dosing occurs, separate syringes recommended.

Both mitochondrial peptides in aqueous BAC water solution. Community-reported combination with no documented incompatibility. Commonly combined in longevity stacks.

Gonadorelin requires very precise pulsatile dosing — mixing with other peptides complicates dose accuracy. Always inject alone to maintain dosing precision. The twice-daily SubQ protocol requires clean, accurate dosing.

Cerebrolysin is a complex multi-peptide preparation with specific formulation pH. Never dilute or mix with other preparations. Administer as supplied, alone.

IGF-1 LR3 is typically injected post-workout at a separate time from morning/evening secretagogue injections. If same-time injection required, no known chemical incompatibility — but monitor for any precipitation. Separate syringes preferred.

Copper peptides can interact with other peptides containing cysteine or histidine residues via copper coordination chemistry. No definitive incompatibility data for this combination — but separate syringes are recommended as a precaution.

Oxytocin has a narrow pH stability range. Mixing introduces risk of pH shift and degradation. Always administer alone, either SubQ or intranasal.

Both GH-axis peptides reconstituted in BAC water at similar pH. Community-reported combination for body composition stacks. No documented incompatibility. Common morning fasted combination.

Both administered intranasally — not injected. No mixing required. Use separate dropper/spray bottles. Timing: many users take Selank first (anxiolytic), Semax second (stimulating). Do not mix in the same bottle.

VIP is administered intranasally in CIRS protocols. Never mix with other preparations. Use as supplied, separate from any injectable protocols.